$ALVR investors, if you follow us, you already know about it.
This info hits different after the news. Check it out: https://11th.com/cases/allovir-investor-settlement
If you missed the deadline, don’t miss this update. This is probably the most useful info you’ve read in years about $ALVR — how you can actually recover something: https://11th.com/cases/allovir-investor-settlement
$ALVR has agreed to settle with investors over claims that it misled them about the effectiveness and approval prospects of its lead product, posoleucel.
Who’s eligible?
Anyone who purchased $ALVR shares between January 11, 2023 and December 21, 2023.
Do I need to sell my shares to qualify?
No — you are eligible whether you sold your shares or still hold them.
How much is the payout?
The payout per share is $0.03 — but normally only ~25% of eligible investors file, the effective payout could increase to $0.12.
Can I still file?
Yes — late claims are currently being considered for compensation, subject to approval.
When do payouts happen?
Typically within 8–12 months after court approval of the settlement.
To file your claim: https://11th.com/cases/allovir-investor-settlement
Imagine buying $ALVR at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back.
To all $ALVR investors out there, we’ve got some important news for you: https://11th.com/cases/allovir-investor-settlement
$ALVR is now accepting claims for a $1M settlement it is paying to investors over claims that it misled them about the effectiveness of its lead product, Posoleucel.
Even if you missed the deadline, if you bought $ALVR between January 11, 2023 and December 21, 2023, you still can file for payment here: https://11th.com/cases/allovir-investor-settlement
When we see a stock like this, we know how many damaged investors are out there.
Believe it or not, there’s some good news.
$ALVR investors — you might be surprised, but you actually have a chance to recover your losses. Don’t miss it: https://11th.com/cases/allovir-investor-settlement
$ALVR has agreed to settle with investors over claims that it misled them about the effectiveness of its lead product, posoleucel.
Who’s eligible?
Anyone who purchased $ALVR shares between January 11, 2023 and December 21, 2023.
Do I need to sell my shares to qualify?
No — you are eligible whether you sold your shares or still hold them.
How much is the payout?
The payout per share is $0.03 — but if only ~25% of eligible investors file, the effective payout could increase to $0.12.
Can I still file?
Yes — claims are currently being accepted.
When do payouts happen?
Typically within 8–12 months after court approval of the settlement.
To file your claim: https://11th.com/cases/allovir-investor-settlement
Don't forget that there is also an important settlement to watch for $ALVR.
We have every detail, including how investors can get paid.
https://11th.com/cases/allovir-investor-settlement
$ALVR investors — there’s no hidden secret here. Just one thing you really need to know.
Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more.
https://11th.com/cases/allovir-investor-settlement
$ALVR investors — there’s no hidden secret here. Just one thing you really need to know.
Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more. #AlloVir #ALVR
https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=11182025
$ALVR is now accepting claims for a $1M settlement it is paying to investors over claims that it misled them about the effectiveness of its lead product, Posoleucel.
Even if you missed the deadline, if you bought $ALVR between January 11, 2023, and December 21, 2023, you still can file for payment here: https://11th.com/cases/allovir-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=11042025
